NEW YORK (GenomeWeb News) – The microplate instrument and software maker BioTek Instruments is collaborating with Promega to offer a screening method for cell viability, cytotoxicity, and apoptosis.
The collaboration involves an integration of BioTek's Precision SX Automated Sample Processor and Promega's microwell cell-based assays that will provide a cell-based screening method to "obtain more biologically relevant data per well," the firms said.
BioTek Product Manager Jason Greene said in a statement that the company's sample processing platform cost, "ease of use, and small size lends itself to the small scale automation" of Promega's cell-based assays.
Terms of the collaboration were not disclosed.